CA Stock MarketDetailed Quotes
LBL.H Lattice Biologics Ltd
- 0.040
- 0.0000.00%
15min DelayMarket Closed Apr 12 09:30 ET
5.13MMarket Cap-3076P/E (TTM)
0.000High0.000Low0Volume0.000Open0.040Pre Close0.00Turnover0.04052wk High0.00%Turnover Ratio128.22MShares0.04052wk Low-0.013EPS TTM4.18MFloat Cap0.040Historical HighLossP/E (Static)104.61MShs Float0.040Historical Low-0.013EPS LYR0.00%Amplitude--Dividend TTM40.00P/B1Lot Size--Div YieldTTM
Lattice Biologics Ltd Key Stats
Quarterly+Annual
YOY
| (Q3)Jun 30, 2021 | (Q2)Mar 31, 2021 | (Q1)Dec 31, 2020 | (FY)Sep 30, 2020 | (Q4)Sep 30, 2020 | (Q3)Jun 30, 2020 | (Q2)Mar 31, 2020 | (Q1)Dec 31, 2019 | (FY)Sep 30, 2019 | (Q4)Sep 30, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -1,486.00%-539.75K | -484.90%-146.77K | 231.72%536.15K | 3,231.22%459.08K | 0 | -67.74%38.94K | 169.08%38.13K | -38.80%161.63K | -93.32%13.78K | |
| Net income from continuing operations | ---- | 51.11%-417.39K | -285.06%-269.13K | -46.52%-1.48M | 16.31%-559.02K | --0 | -1,477.52%-853.72K | 39.09%-69.89K | 17.80%-1.01M | -118.13%-667.94K |
| Operating gains losses | ---- | ---- | 986.24%37.36K | 66.33%39.2K | -1,070.89%-347.8K | --0 | 1,207.60%391.22K | 74.48%-4.22K | 103.49%23.57K | 106.41%35.82K |
| Depreciation and amortization | ---- | ---- | -15.10%64K | 86.63%380.9K | 345.10%231.43K | --0 | 48.03%74.09K | 50.63%75.39K | 1.45%204.1K | 3.12%52K |
| Asset impairment expenditure | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --15.35K | ---- |
| Remuneration paid in stock | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -86.43%21.01K | -98.34%1.32K |
| Other non cashItems | ---- | ---- | -29.84%45.11K | -130.71%-74.43K | -764.04%-438.31K | --0 | 406.03%299.58K | 14.14%64.3K | -21.21%242.41K | -63.06%66.01K |
| Change In working capital | ---- | ---- | 12.16%-24.11K | 150.80%1.67M | 207.65%1.57M | --0 | 245.64%127.77K | -187.40%-27.44K | -55.73%667.11K | -32.98%511.23K |
| -Change in receivables | ---- | ---- | 165.82%111.4K | 76.24%-25.65K | -261.39%-77.59K | --0 | 244.07%221.21K | -11.26%-169.26K | -337.88%-107.92K | 178.85%48.08K |
| -Change in inventory | ---- | ---- | -133.20%-56.44K | -76.34%184.64K | -74.40%149.54K | --0 | -888.02%-134.89K | 130.06%170K | 114.47%780.5K | 298.62%584.13K |
| -Change in prepaid assets | ---- | ---- | -127.70%-2.68K | 148.49%19.06K | 210.31%41.74K | --0 | ---21.5K | ---1.18K | -246.18%-39.31K | -534.71%-37.84K |
| -Change in payables and accrued expense | ---- | ---- | -182.91%-76.39K | 3,445.57%1.5M | 1,855.06%1.46M | --0 | 29.31%62.96K | -122.89%-27K | -96.51%42.17K | -112.30%-83.14K |
| -Change in other current liabilities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 91.66%-8.33K | --0 |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | --2.13K | -1,486.00%-539.75K | -484.90%-146.77K | 231.72%536.15K | 3,231.22%459.08K | --0 | -67.74%38.94K | 169.08%38.13K | -38.80%161.63K | -93.32%13.78K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | -1,039.33%-592.08K | -37,258.97%-567.79K | 0 | -8.79K | -15.5K | 77.48%-51.97K | 100.76%1.53K | ||
| Net PPE purchase and sale | ---- | ---- | --0 | -1,039.33%-592.08K | -37,258.97%-567.79K | --0 | ---8.79K | ---15.5K | 77.48%-51.97K | 100.76%1.53K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---- | --0 | --0 | -1,039.33%-592.08K | -37,258.97%-567.79K | --0 | 82.42%-8.79K | ---15.5K | 77.48%-51.97K | 100.76%1.53K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 677.20%113.74K | 197.05%97.48K | 2,896.46%155.82K | 0 | 46.62%-38.64K | -5.44%-19.71K | -119.89%-100.44K | -2,455.96%-5.57K | ||
| Net issuance payments of debt | ---- | ---- | 677.20%113.74K | 197.05%97.48K | 2,896.46%155.82K | --0 | 46.62%-38.64K | -5.44%-19.71K | -119.89%-100.44K | -2,455.96%-5.57K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | ---- | 1,578.26%571.13K | 677.20%113.74K | 197.05%97.48K | 2,896.46%155.82K | --0 | 46.62%-38.64K | -5.44%-19.71K | -119.89%-100.44K | -2,455.96%-5.57K |
| Net cash flow | ||||||||||
| Beginning cash position | 155.52%25.85K | 30.10%24.19K | 265.18%57.22K | 143.01%15.67K | 70.52%10.12K | 3,578.18%10.12K | 863.97%18.6K | 143.01%15.67K | -65.74%6.45K | 1,200.88%5.93K |
| Current changes in cash | ---27.5K | 508.96%34.68K | -1,228.74%-33.03K | 350.61%41.55K | 383.77%47.11K | --0 | -412.70%-8.48K | 164.75%2.93K | 174.53%9.22K | 62.50%9.74K |
| End cash Position | --0 | 155.52%25.85K | 30.10%24.19K | 265.18%57.22K | 265.18%57.22K | 70.52%10.12K | 3,578.18%10.12K | 863.97%18.6K | 143.01%15.67K | 143.01%15.67K |
| Free cash from | --2.13K | -1,889.92%-539.75K | -748.51%-146.77K | -151.00%-55.93K | -810.13%-108.71K | --0 | -75.02%30.16K | 59.71%22.63K | 229.28%109.66K | 146.52%15.31K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data